Medtronic Sees U.S. Medical Device Tax Cutting 2013 Earnings

Medtronic Inc., the world’s biggest-maker of heart rhythm devices, said it is planning for a U.S. tax on medical products that will cost the company $125 million to $175 million annually starting next year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.